Transactivation domain of Krüppel‐like factor 15 negatively regulates angiotensin II–induced adventitial inflammation and fibrosis. Issue 5 (18th February 2019)

• Record Type: Journal Article
• Authors: Lu, Yuan‐Yuan; Li, Xiao‐Dong; Zhou, Han‐Dan; Shao, Shuai; He, Shun; Hong, Mo‐Na; Liu, Jia‐Chen; Xu, Ying‐Le; Wu, Yong‐Jie; Zhu, Ding‐Liang; Wang, Ji‐Guang; Gao, Ping‐Jin
• Is Part Of: FASEB journal. Volume 33:Issue 5(2019)
• Page Start: 6254
• Page End: 6268
• Publication Date: 2019-02-18
• Subjects: KLF15 -- Ang II -- vascular remodeling -- adenovirus -- macrophage; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201801809R
• Languages: English
• ISSNs: 0892-6638

Abstract

ABSTRACT: Krüppel‐like factor (KLF) 15 has emerged as a critical regulator of fibrosis in cardiovascular diseases. However, the precise role that KLF15 and its functional domain played in adventitial inflammation and fibrosis remains unclear. This study aims to investigate the role of the transactivation domain (TAD) of KLF15 in angiotensin II (Ang II)–induced adventitial pathologic changes. KLF15 expression was decreased in the vascular adventitia of Ang II–infused mice (1000 ng/kg/min, 14 d) and in adventitial fibroblasts (AFs) stimulated by Ang II (10 −7 M). Adenovirus‐mediated KLF15 overexpression normalized Ang II–induced vascular hypertrophy, increased collagen deposition, macrophage infiltration, and CCL2 and VCAM‐1 expression. Interestingly, KLF15‐ΔTAD (KLF15 with deletion of TAD at amino acids 132–152) overexpression showed no effect on the above pathologic changes. Similarly, perivascularly over‐expression of KLF15 but not KLF15‐ΔTAD in carotid arteries also attenuated Ang II–induced vascular inflammation and fibrosis. Furthermore, KLF15 overexpression after Ang II infusion rescued Ang II–induced vascular remodeling. CCL2 or VCAM‐1–mediated monocyte and macrophage migration or adhesion to AFs in response to Ang II was negatively regulated by KLF15 through TAD. Ang II–enhanced Smad2/3 activation and adventitial migration, proliferation, and differentiation of AFs were suppressed by KLF15 but not KLF15‐ΔTAD overexpression. Conversely, small interfering RNA knockdown of KLF15 aggravated Ang II–induced Smad2/3 activation and dysfunction of AFs. Luciferase, coimmunoprecipitation, and chromatin immunoprecipitation assay were used to demonstrate that interaction of KLF15 with Smad2/3 suppressed CCL2 expression through TAD. Mechanistically, activation of Ang II type 1 receptor/phospholipase C γ 1/ERK1/2 signaling resulted in a decrease of KLF15 expression. In conclusion, these results demonstrate that KLF15 negatively regulates activation of AFs through TAD, which plays an important role in Ang II–induced adventitial inflammation and fibrosis.—Lu, Y.‐Y., Li, X.‐D., Zhou, H.‐D., Shao, S., He, S., Hong, M.‐N., Liu, J.‐C., Xu, Y.‐L., Wu, Y.‐J., Zhu, D.‐L., Wang, J.‐G., Gao, P.‐J. Transactivation domain of Krüppel‐like factor 15 negatively regulates angiotensin II–induced adventitial inflammation and fibrosis. FASEB J. 33, 6254–6268 (2019). www.fasebj.org